Europe Influenza Diagnostics Market Size study, by Test Type (RIDT, RT-PCR, Cell Culture, Others), by End Use (Hospitals, POCT, Laboratories) and Country Forecasts 2022-2032
Europe Influenza Diagnostics Market is valued at approximately USD 420 million in 2023 and is anticipated to grow with a healthy growth rate of more than 6.55% over the forecast period 2024-2032. Influenza diagnostics encompass the techniques and instruments employed for detecting and diagnosing influenza virus infections in individuals. These diagnostic measures are vital for public health, enabling timely identification, treatment, and containment of influenza outbreaks. Also, the Influenza Diagnostics Market was witnessing significant advancements in technology, particularly in molecular diagnostics and point-of-care testing. These advancements aimed to improve the accuracy, speed, and efficiency of influenza diagnosis which anticipated to support the growth of Influenza Diagnostics Market.
Moreover, rising healthcare expenditure in Europe allows for greater investment in diagnostic infrastructure and healthcare facilities, facilitating the growth of the Influenza Diagnostics Market. Also, as influenza remains a significant public health concern, the rising incidence of influenza cases in Europe drives the demand for diagnostic tests. Additionally, other factors that support the market growth are continuous advancements in diagnostic technologies, increased healthcare expenditure, and increasing demand for point-of-care testing. However, the lack of skilled professionals, and stringent regulatory frameworks are expected to hinder the market growth during the forecast period 2024-2032.
The key countries considered for the Europe Influenza Diagnostics market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market. The cohesive government initiatives aimed at controlling the spread of influenza and improving healthcare infrastructure can contribute to the growth of the diagnostics market by increasing accessibility to testing facilities. Also, with increasing awareness among both healthcare professionals and the general population about the importance of early diagnosis and treatment of influenza, there's likely to be a higher demand for diagnostic tests. Whereas, the United Kingdom is expected to grow with the highest CAGR during the forecast period 2024-2032.
Major market player included in this report are:
F. Hoffmann-LA Roche AG
Koninklijke Philips N.V.
Siemens AG
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Test Type
RIDT
RT-PCR
Cell Culture
Others
By End Use
Hospitals
POCT
Laboratories
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
Moreover, rising healthcare expenditure in Europe allows for greater investment in diagnostic infrastructure and healthcare facilities, facilitating the growth of the Influenza Diagnostics Market. Also, as influenza remains a significant public health concern, the rising incidence of influenza cases in Europe drives the demand for diagnostic tests. Additionally, other factors that support the market growth are continuous advancements in diagnostic technologies, increased healthcare expenditure, and increasing demand for point-of-care testing. However, the lack of skilled professionals, and stringent regulatory frameworks are expected to hinder the market growth during the forecast period 2024-2032.
The key countries considered for the Europe Influenza Diagnostics market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany was the largest market. The cohesive government initiatives aimed at controlling the spread of influenza and improving healthcare infrastructure can contribute to the growth of the diagnostics market by increasing accessibility to testing facilities. Also, with increasing awareness among both healthcare professionals and the general population about the importance of early diagnosis and treatment of influenza, there's likely to be a higher demand for diagnostic tests. Whereas, the United Kingdom is expected to grow with the highest CAGR during the forecast period 2024-2032.
Major market player included in this report are:
F. Hoffmann-LA Roche AG
Koninklijke Philips N.V.
Siemens AG
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10
The detailed segments and sub-segment of the market are explained below:
By Test Type
RIDT
RT-PCR
Cell Culture
Others
By End Use
Hospitals
POCT
Laboratories
By Region:
Europe
UK
Germany
France
Spain
Italy
ROE
Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market
CHAPTER 1. EUROPE INFLUENZA DIAGNOSTICS MARKET DEFINITION AND RESEARCH ASSUMPTIONS
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Europe Influenza Diagnostics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Test Type
2.3.2. By End Use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
CHAPTER 3. EUROPE INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. EUROPE INFLUENZA DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. EUROPE INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY TEST TYPE 2022-2032
5.1. RIDT
5.2. RT-PCR
5.3. Cell Culture
5.4. Others
CHAPTER 6. EUROPE INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY END USE 2022-2032
6.1. Hospitals
6.2. POCT
6.3. Laboratories
CHAPTER 7. EUROPE INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY COUNTRY 2022-2032
7.1. U.K. Influenza Diagnostics Market
7.1.1. Test Type breakdown size & forecasts, 2022-2032
7.1.2. End Use breakdown size & forecasts, 2022-2032
7.2. Germany Influenza Diagnostics Market
7.3. France Influenza Diagnostics Market
7.4. Spain Influenza Diagnostics Market
7.5. Italy Influenza Diagnostics Market
7.6. Rest of Europe Influenza Diagnostics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. F. Hoffmann-LA Roche AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Koninklijke Philips N.V.
8.3.3. Siemens AG
8.3.4. Company
8.3.5. Company
8.3.6. Company
8.3.7. Company
8.3.8. Company
8.3.9. Company
8.3.10. Company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Europe Influenza Diagnostics Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Test Type
2.3.2. By End Use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
CHAPTER 3. EUROPE INFLUENZA DIAGNOSTICS MARKET DYNAMICS
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
CHAPTER 4. EUROPE INFLUENZA DIAGNOSTICS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
CHAPTER 5. EUROPE INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY TEST TYPE 2022-2032
5.1. RIDT
5.2. RT-PCR
5.3. Cell Culture
5.4. Others
CHAPTER 6. EUROPE INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY END USE 2022-2032
6.1. Hospitals
6.2. POCT
6.3. Laboratories
CHAPTER 7. EUROPE INFLUENZA DIAGNOSTICS MARKET SIZE & FORECASTS BY COUNTRY 2022-2032
7.1. U.K. Influenza Diagnostics Market
7.1.1. Test Type breakdown size & forecasts, 2022-2032
7.1.2. End Use breakdown size & forecasts, 2022-2032
7.2. Germany Influenza Diagnostics Market
7.3. France Influenza Diagnostics Market
7.4. Spain Influenza Diagnostics Market
7.5. Italy Influenza Diagnostics Market
7.6. Rest of Europe Influenza Diagnostics Market
CHAPTER 8. COMPETITIVE INTELLIGENCE
8.1. Key Company SWOT Analysis
8.1.1. Company
8.1.2. Company
8.1.3. Company
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. F. Hoffmann-LA Roche AG
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. Koninklijke Philips N.V.
8.3.3. Siemens AG
8.3.4. Company
8.3.5. Company
8.3.6. Company
8.3.7. Company
8.3.8. Company
8.3.9. Company
8.3.10. Company
CHAPTER 9. RESEARCH PROCESS
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
LIST OF TABLES
TABLE 1. Europe Influenza Diagnostics market, report scope
TABLE 2. Europe Influenza Diagnostics market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3. Europe Influenza Diagnostics market estimates & forecasts by Test Type 2022-2032 (USD Million)
TABLE 4. Europe Influenza Diagnostics market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 5. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million) Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. UK Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. UK Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 16. UK Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. Germany Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 18. Germany Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 19. Germany Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20. France Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 21. France Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 22. France Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 23. Italy Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 24. Italy Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 25. Italy Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 26. Spain Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 27. Spain Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 28. Spain Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 29. RoE Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 30. RoE Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 31. RoE Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 32. List of secondary sources, used in the study of Europe Influenza Diagnostics Market.
TABLE 33. List of primary sources, used in the study of Europe Influenza Diagnostics Market.
TABLE 34. Years considered for the study.
TABLE 35. Exchange rates considered
TABLE 1. Europe Influenza Diagnostics market, report scope
TABLE 2. Europe Influenza Diagnostics market estimates & forecasts by Country 2022-2032 (USD Million)
TABLE 3. Europe Influenza Diagnostics market estimates & forecasts by Test Type 2022-2032 (USD Million)
TABLE 4. Europe Influenza Diagnostics market estimates & forecasts by End Use 2022-2032 (USD Million)
TABLE 5. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 6. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 7. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 8. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 9. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 10. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 11. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million)
TABLE 12. Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 13. Europe Influenza Diagnostics market by segment, estimates & forecasts, 2022-2032 (USD Million) Europe Influenza Diagnostics market by country, estimates & forecasts, 2022-2032 (USD Million)
TABLE 14. UK Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 15. UK Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 16. UK Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 17. Germany Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 18. Germany Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 19. Germany Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 20. France Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 21. France Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 22. France Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 23. Italy Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 24. Italy Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 25. Italy Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 26. Spain Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 27. Spain Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 28. Spain Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 29. RoE Influenza Diagnostics market estimates & forecasts, 2022-2032 (USD Million)
TABLE 30. RoE Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 31. RoE Influenza Diagnostics market estimates & forecasts by segment 2022-2032 (USD Million)
TABLE 32. List of secondary sources, used in the study of Europe Influenza Diagnostics Market.
TABLE 33. List of primary sources, used in the study of Europe Influenza Diagnostics Market.
TABLE 34. Years considered for the study.
TABLE 35. Exchange rates considered
LIST OF FIGURES
FIG 1. Europe Influenza Diagnostics market, research methodology
FIG 2. Europe Influenza Diagnostics market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Influenza Diagnostics market, key trends 2023
FIG 5. Europe Influenza Diagnostics market, growth prospects 2022-2032
FIG 6. Europe Influenza Diagnostics market, porters 5 force model
FIG 7. Europe Influenza Diagnostics market, pestel analysis
FIG 8. Europe Influenza Diagnostics market, value chain analysis
FIG 9. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 10. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 11. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 12. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 13. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 14. Europe Influenza Diagnostics market, Country snapshot 2022 & 2032
FIG 15. Europe Influenza Diagnostics market 2022 & 2032 (USD Million)
FIG 16. Europe Influenza Diagnostics market, company market share analysis (2023)
FIG 1. Europe Influenza Diagnostics market, research methodology
FIG 2. Europe Influenza Diagnostics market, market estimation techniques
FIG 3. Europe market size estimates & forecast methods.
FIG 4. Europe Influenza Diagnostics market, key trends 2023
FIG 5. Europe Influenza Diagnostics market, growth prospects 2022-2032
FIG 6. Europe Influenza Diagnostics market, porters 5 force model
FIG 7. Europe Influenza Diagnostics market, pestel analysis
FIG 8. Europe Influenza Diagnostics market, value chain analysis
FIG 9. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 10. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 11. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 12. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 13. Europe Influenza Diagnostics market by segment, 2022 & 2032 (USD Million)
FIG 14. Europe Influenza Diagnostics market, Country snapshot 2022 & 2032
FIG 15. Europe Influenza Diagnostics market 2022 & 2032 (USD Million)
FIG 16. Europe Influenza Diagnostics market, company market share analysis (2023)
